Five Prime Therapeutics relocates into new drug discovery facility in South San Francisco

Five Prime Therapeutics, Inc., a leader in biologics, has relocated into its state-of-the-art drug discovery facility in South San Francisco. The new facility provides FivePrime with a two fold increase in square footage without significant incremental rental cost. The relocation includes an expanded laboratory facility for the Company to accelerate its innovative and proprietary protein therapeutic and antibody drug discovery platform.

"Following a strategic assessment of our requirements, we addressed the need to further expand our drug discovery and development infrastructure. Our new streamlined facility will better enable our novel, technologically driven approach to finding first in class therapeutics. FivePrime is now optimally positioned to meet its goals and objectives over the next several years," stated Julia P. Gregory, president and chief executive officer. "South San Francisco has proven to be a stimulating environment for employees and its many successful biotech companies."

FivePrime's new address is the following:
Two Corporate Drive
South San Francisco, CA 94080-7047